— Know what they know.
Not Investment Advice

NVCR NASDAQ

Novocure Ltd
1W: -5.7% 1M: -16.2% 3M: -13.7% YTD: +13.9% 1Y: +6.9% 3Y: -12.1% 5Y: -88.3%
$14.94
-0.98 (-6.16%)
 
Weekly Expected Move ±6.6%
$13 $14 $15 $16 $17
NASDAQ · Healthcare · Medical - Devices · Tech Score Sell · Power 40 · $1.7B mcap · 96M float · 1.57% daily turnover · Short 45% of daily vol

📊 Key Metrics

TTM
$699M
Revenue
+11.0% YoY
$-149M
Net Income
+13.1% YoY
$-21M
Free Cash Flow
+73.7% YoY
77.6%
Gross Margin
-5.8%
Op. Margin
-8.5%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-43.2%
ROA-14.6%
ROIC-93.1%

Valuation

P/E-11.5
P/B5.1
EV/EBITDA-11.5

Leverage

Debt/Equity0.69
Current Ratio2.89
Interest Cov.-62.1x

Quality Scores

Piotroski F6/9
Altman Z0.77
Beneish M-3.39

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms